Fund moves
15.0%Stake
A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 3, 2026 · Filed Nov 4, 2026
The CFO of Fate Therapeutics sold $14K of Fate Therapeutics shares. The filing references tax withholding.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$13,525
Shares × reported transaction price
82 days after results of Aug 13, 2026, 2 days before results of Nov 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $2.04 on Nov 3, 2026, 112% above its 52-week low and 34% below its high, after a 21% drop over the previous 30 trading days
52-week range $0.964 (Nov 14, 2025) to $3.11 (Jul 9, 2026), 50% of the way up, from 250 adjusted closes. 30 trading days earlier: $2.58 on Sep 22, 2026. Describes the past only, not a forecast
RSI 44, 4% above its 200-day average, 10% under its 50-day average, 34% below the 52-week high, 20-day volatility 66% a year, against the S&P 500: −13 points over 1 month, −18 points over 3 months, +8 points over 6 months
From the adjusted closes up to Nov 3, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −27.6% | +3.3% | −30.9% |
Past results only. Not a forecast.
Fund moves
A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
Adawi Kamal (Officer) plans to sell ~$14K of Fate Therapeutics
Planned, from payEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.